Malignant mesothelioma: current practice and research directions

Collegian

Volumn 11, Issue 2, 2004, Pages 22-26

  Hawley, Rhonda ^a   Monk, Amy ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

caregivers; home care; hospitalisation; mesothelioma; palliative care

Indexed keywords

EID: 84875641464     PISSN: 13227696     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1322-7696(08)60451-5     Document Type: Article

References (50)

1. ACN Working Party on the Management of Lung Cancer, Clinical Practice Guidelines for the Management of Lung Cancer, September 2002 Draft, 2002, Australian Cancer Network, Sydney.
2. Aisner, J, Current approach to malignant mesothelioma of the pleura. Chest 107:6 Suppl (1995), 332S–344S.
3. Barak, Y, Achiron, A, Rotstein, Z, Elizur, A, Noy, S, Stress associated with asbestosis: the trauma of waiting for death. Psycho-Oncology(7), 1998, 126–128.
4. Bissett, D, MacBeth, FR, Cram, I, The role of palliative radiotherapy in malignant mesothelioma. Journal of Clinical Oncology 3:6 (1991), 315–327.
5. Booth, S, Kelly, MJ, Cox, NP, Adams, L, Guz, A, Does oxygen help dyspnea in patients with cancer?. American Journal of Respiratory & Critical Care Medicine 153:5 (1996), 1515–1518.
6. Boyd, KJ, Kelly, M, Oral morphine as symptomatic treatment of dyspnoea in patients with advanced lung cancer. Palliative Medicine 11:4 (1997), 277–281.
7. Bruera, E, Macmillan, K, Pither, J, MacDonald, RN, Effects of morphine on the dyspnea of terminal cancer patients. Journal of Pain & Symptom Management 5:6 (1990), 341–344.
8. Cartwright, A, Balance of care for the dying between hospitals and the community: perceptions of general practitioners, hospital consultants, community nurses and relatives. British Journal of General Practice 41:July (1991), 271–274.
9. Chin, YS, Yeghaian-Alvandi, R, Noel, M, Radiotherapy for the palliation of high volume pleural effusion in malignant mesothelioma: case report. Palliative Medicine 16:1 (2002), 63–64.
10. Clark, D, Between hope and acceptance: the medicalisation of dying. British Medical Journal 324:7342 (2002), 905–907.
11. Connelly, RR, Spirtas, R, Myers, MH, Percy, CL, Fraumeni, JF, Demographic patterns for mesothelioma in the United States. Journal of the National Cancer Institute 78:6 (1987), 1053–1060.
12. Cooley, ME, Symptoms in adults with lung cancer: a systematic research review. Journal of pain and Symptom Management 19:2 (2000), 137–153.
13. De Graaf-Strukowska, L, van der Zee, J, van Putten, W, Senan, S, Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura: a single-institution experience with 189 patients. International Journal of Radiation Oncology, Biology, Physics 43:3 (1999), 511–516.
14. Evans, N, Walsh, H, The organisation of death and dying in today's society. Nursing Standard 16:25 (2002), 33–38.
15. Fainsinger, RL, Demoissac, D, Cole, J, Mead-Wood, K, Lee, E, Home versus hospice inpatient care: discharge characteristics of palliative care patients in an acute care hospital. Journal of Palliative Care 16:1 (2000), 29–34.
16. Fakhoury, W, McCarthy, M, Addington-Hall, J, Determinants of informal caregivers' satisfaction with services for dying cancer patients. Social Science and Medicine 42:5 (1996), 721–731.
17. Field, D, McGaughey, J, An evaluation of palliative care services for cancer patients in the Southern Health and Social Services Board of Northern Ireland. Palliative Medicine 12:2 (1998), 83–97.
18. Fizazi, K, John, WJ, Vogelzang, NJ, The emerging role of antifolates in the treatment of malignant pleural mesothelioma. Seminars in Oncology 29:1 (2002), 77–81.
19. Fried, TR, van Doorn, C, O'Leary, JR, Tinetti, ME, Drickamer, MA, Older persons' preferences for site of terminal care. Annals of Internal Medicine 131:2 (1999), 109–112.
20. Gilbar, O, Steiner, M, When death comes: where should patients die?. The Hospice Journal 11:1 (1996), 31–48.
21. Hinton, J, Can home care maintain an acceptable quality of life for patients with terminal cancer and their relatives?. Palliative Medicine 8:3 (1994), 183–196.
22. Johnson A, Rimmer J, Berry G, Lee J 1995 Work-related malignant mesothelioma in NSW. The Workers Compensation (Dust Diseases) Board of NSW pp1-6. Retrieved May 7 2002 from the World Wide Web: http://www.ddb.nsw.gov.au./parent.asp?disp=re.
23. Johnson A 2000 The incidence of dust diseases compensated in NSW. Occupational Respiratory Health Report Special Edition (October): 3-8.
24. Jones, RVH, Hansford, J, Fiske, J, Death from cancer at home: the carer's perspective. British Medical Journal 306:6872 (1993), 249–250.
25. Krech, R, Davis, J, Walsh, D, Symptoms of lung cancer. Palliative Medicine 6 (1992), 309–315.
26. Langer, AM, Pooley, FD, Identification of single asbestos fibres in human tissue. Bogovski, P, Gilson, JC, Timbrell, V, Wagner, JC, (eds.) Biological effects of asbestos, 1973, The International Agency for Research on Cancer, France, Lyon, 119–124.
27. Leigh, J, Davidson, P, Hendrie, L, Berry, D, Malignant mesothelioma in Australia, 1945-2000. American Journal of Industrial Medicine 41:3 (2002), 188–201.
28. Lynn, J, Teno, JM, Phillips, RS, Wu, AW, Desbiens, N, Harrold, J, Claessens, MT, Wenger, N, Kreling, B, Connors, AF, Perceptions by family members of the dying experience of older and seriously ill patients. Annals of Internal Medicine 126:2 (1997), 97–106.
29. McGrath, P, Caregivers' insights on the dying trajectory in hematology oncology. Cancer Nursing: An International Journal for Cancer Care 24:5 (2001), 413–421.
30. Marsh, GM, Gula, MJ, Youk, AO, Buchanich, JM, Churg, A, Colby, TV, Historical cohort study of US man-made vitreous fiber production workers: II. Mortality from mesothelioma. Occupational and Environmental Medicine 43:9 (2001), 757–766.
31. Meek, PM, Schwartz, RM, Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Journal of Respiratory and Critical Care Medicine 159 (1999), 321–341.
32. Munson, M, Mesothelioma. Professional Nurse 12:9 (1997), 651–653.
33. National Occupational Health and Safety Commission 2001 The incidence of mesothelioma in Australia 1996 to 1998. Australian Mesothelioma Register Report. Canberra, pp1-30.
34. Ong, S, Vogelzang, N, Chemotherapy in malignant pleural mesothelioma: a review. Journal of Clinical Oncology 14 (1996), 1007–1017.
35. Prior, D, Poulton, V, Palliative care nursing in a curative environment: an Australian perspective. International Journal of Palliative Nursing 2:2 (1996), 84–90.
36. Radbruch, L, Sabatowski, R, Loick, G, Kulbe, C, Kasper, M, Grond, S, Lehmann, KA, Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliative Medicine 14 (2000), 111–119.
37. Ratner, E, Norlander, L, McSteen, K, Death at home following a targeted advance care planning process at home: the kitchen table discussion. Journal of the American Geriatrics Society 49:6 (2001), 778–781.
38. Rom, WN, Travis, WD, Brody, AR, Cellular and molecular basis of the asbestosrelated diseases [comment]. American Review of Respiratory Disease 143:2 (1991), 408–422.
39. Rusch, V, Saltz, L, Venkatraman, E, Ginsberg, R, McCormack, P, Burt, M, Markman, M, Kelsen, D, A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. Journal of Clinical Oncology 12 (1994), 1156–1163.
40. Ryan, CW, Herndon, J, Vogelzang, NJ, A review of chemotherapy trials for malignant mesothelioma. Chest 113:1 Suppl (1998), 66S–73S.
41. Seale, C, Addington-Hall, J, McCarthy, M, Awareness of dying: prevalence, causes and consequences. Social Science and Medicine 45:3 (1997), 477–484.
42. Smythe, WR, Current therapy for malignant mesothelioma. Current Oncology Reports 4:4 (2002), 305–313.
43. Steele, JPC, The new front line treatment for malignant pleural mesothelioma. Thorax 58:2 (2003), 96–97.
44. Steinhauser, KE, Christakis, NA, Clipp, EC, McNeilly, M, Grambow, S, Parker, J, Tulsky, JA, Preparing for the end of life: preferences of patients, families, physicians, and other care providers. Journal of Pain and Symptom Management 22:3 (2001), 727–737.
45. Sugarbaker, DJ, Garcia, JP, Richards, WG, Harpole, DH, Healy-Baldini, E, DeCamp, MM, Mentzer, SJ, Liptay, MJ, Strauss, GM, Swanson, SJ, Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Annals of Surgery 224:3 (1996), 288–294.
46. Takahashi, K, Huuskonen, MS, Tossavainen, A, Higashi, T, Okubo, T, Rantanen, J, Ecological relationship between mesothelioma incidence/mortality and asbestos consumption in ten western countries and Japan. Journal of Occupational Health 41:1 (1999), 8–11.
47. Townsend, J, Frank, AO, Fermont, D, Dyer, S, Karran, O, Walgrove, A, Piper, M, Terminal cancer care and patients' preference for place of death: a prospective study [comment]. British Medical Journal 301:6749 (1990), 415–417.
48. Tracey EA, Supramaniam R 2002 Cancer in New South Wales: incidence and mortality 2000, featuring projections to 2010, for selected sites. The Cancer Council New South Wales. Retrieved March 7 2003 from the World Wide Web: http://www.cancercouncil.com.au/cncrinfo/research/reports/stats/index.htm.
49. Vainio, A, Auvinen, A, Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Journal of Pain and Symptom Management 12:1 (1996), 3–10.
50. Zellos, L, Sugarbaker, DJ, Current surgical management of malignant pleural mesothelioma. Current Oncology Reports 4:4 (2002), 354–360.